The Annals of otology, rhinology, and laryngology · 2020
Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kohli Nikita, Blitzer Andrew
Аннотация
OBJECTIVE: To present a unique approach to the treatment of motor and phonic tics.
PATIENT: A 26-year-old male presented with motor and phonic tics including grunting, coughing, and throat clearing.
INTERVENTION: The patient was treated with 2.5 units of onabotulinum toxin A (BoNT) to the facial mimetic musculature and 2.5 units to each supraglottic musculature via a transthyrohyoid membrane approach under fiberoptic visualization.
RESULTS: The patient experienced reduction in the frequency, intensity, and interference with daily life of motor and phonic tics on the Yale Global Tic Severity Scale (YGTSS).
CONCLUSION: This patient experienced subjective and objective decreases in tic severity using a unique approach in the treatment of phonic tics. Results suggest a novel approach in the treatment of phonic tics and bolster the data regarding safe and effective use of BoNT for tic disorder.
LEVEL OF EVIDENCE: Level V, case report.
PATIENT: A 26-year-old male presented with motor and phonic tics including grunting, coughing, and throat clearing.
INTERVENTION: The patient was treated with 2.5 units of onabotulinum toxin A (BoNT) to the facial mimetic musculature and 2.5 units to each supraglottic musculature via a transthyrohyoid membrane approach under fiberoptic visualization.
RESULTS: The patient experienced reduction in the frequency, intensity, and interference with daily life of motor and phonic tics on the Yale Global Tic Severity Scale (YGTSS).
CONCLUSION: This patient experienced subjective and objective decreases in tic severity using a unique approach in the treatment of phonic tics. Results suggest a novel approach in the treatment of phonic tics and bolster the data regarding safe and effective use of BoNT for tic disorder.
LEVEL OF EVIDENCE: Level V, case report.